Scrip : Alembic Pharma
Date of Incorporation : 1907
Registered Office : Vadodara, Gujarat
Chairman : Chirayu A Amin
Face Value : Rs.2
Market Price : Rs.52
Target Price : Rs.75
EPS 2011-12 : Rs.6.90
Book Value : Rs.20.95
P/E Ratio : 7.53
52-Week High/Low : Rs.59.95/34
Group : Alembic Group
Products : Pharmaceutical Business
Recommendation : Buy
Financial Highlights:
Rs in LakhsParticulars 31/03/2012 QE 31/03/2012 YE 31/03/2012
Net Sales 34261 29732 146639
Total Expenditure 30149 27012 124597
Other Income 13 3 44
Interest 538 636 2621
Tax Expense 526 51 3123
Net Profit 2031 1028 13014
Equity (FV: Rs.2) 3770 3770 3770
Res Ex Rev Reserves - - 35730
EPS (Rs) 1.08 0.55 6.9
Reasons for Recommendation:
* Company with good track record
Rise in sales and profitability
Increase in Earnings Per share
EPS of Rs.6.9 with P/E multiple of 7.53
Dividend of 70% declared for 2011-12
Book Value: Rs.20.95 (FV: Rs.2)
Assuming a P/E multiple of a conservative 12 against industry average of around 24 times , the projected price is Rs.75 in the short to medium term
Disclaimer: All the information/recommendation provided herein are for information purposes only. Readers should consult their investment advisors before making investment decision. The information is given as a matter of service and in good faith. We do not accept liability for actions on the basis of information given herein.
No comments:
Post a Comment